Stock Analysts

Will E*TRADE (ETFC) Continue to Perform Strongly in 2016?

On Dec 28, 2015, we have issued an updated research report on E*TRADE Financial Corporation ETFC . Shares of this New York-based investment brokerage firm have been moving up since late August, depicting investors’ optimism over its balance sheet restructuring plan. Notably, the company has returned roughly 22% year to date. […]

Stock Analysts

Deutsche Bank to Vend Hua Xia Stake to Bolster Capital

In an effort to bolster its capital position, Deutsche Bank AG DB has inked a deal to sell its entire stake in China-based Hua Xia Bank. Notably, state-owned Chinese insurer – PICC Property and Casualty Company Limited – is taking over Deutsche Bank’s 19.99% stake in Hua Xia for 23.0–25.7 billion yuan (around €3.2–€3.7 billion). The transaction is currently subject to customary closing conditions and regulatory approvals […]

Stock Analysts

First Potomac Divests Cedar Hill I and III for $27.3 Million

In sync with its strategy to strengthen balance sheet and enhance shareholders’ value, First Potomac Realty Trust FPO announced the divestiture of Cedar Hill I and III located in Tyson’s Corner, VA. The sale of the two office buildings, spanning 102,632 square feet, will likely fetch gross proceeds of $27.3 million for the Bethesda, MD-based real estate investment trust (“REIT”). […]

Stock Analysts

Regency (REG) Focuses on Premium Portfolio to Drive Growth

We have issued an updated research report on Regency Centers Corporation REG on Dec 28, 2015. The Jacksonville, FL-based retail real estate investment trust (“REIT”) primarily aims to build a premium portfolio of grocery-anchored shopping centers. Such centers are usually necessity-driven and Internet-resistant in nature, thus driving dependable traffic […]

Stock Analysts

Philips Stays Closely Connected to Boost Lighting Business

Diversified health and well-being company Koninklijke Philips N.V. PHG is making some concerted efforts to strengthen its lighting business for greater profitability. In what can be called a sly marketing attempt, the company recently declared a special offer for its Philips Hue light users to synchronize their home lighting with one of the most iconic festive frenzies, the Times Square Ball drop […]

Stock Analysts

3D Systems Trims Portfolio, Discontinues Entry-Level Cubes

Premium provider of comprehensive 3D digital design and fabrication solutions, 3D Systems Corp. DDD , recently announced its decision to cease the production of Cube, the entry-level consumer 3D printer. This initiative comes as part of the company’s plan to channelize its resources toward more lucrative areas in professional and industrial markets. […]

Stock Analysts

Hormel Eyes Growth Despite Headwinds: Should You Buy?

We have issued an updated research report on the premium meat products company Hormel Foods Corporation HRL on Dec 28, 2015. The company produces and sells a variety of meat and other food items on a global basis. However, despite holding a high brand value in the market, the firm is currently plagued by certain headwinds in its business […]

Stock Analysts

AT&T to Air Entertainment Studios Content, Lawsuit Resolved

U.S.telecom behemoth AT&T Inc. T has inked a deal with Entertainment Studios to provide the latter’s channels to its U-verse TV and DIRECTV customers. The deal includes broadcast of the entire suite of Entertainment Studios’ channels, including some of the prominent brands in its portfolio, namely Comedy.TV, Recipe.TV, ES.TV, MyDestination.TV, Cars TV, Pets TV and Justice Central.TV […]

Stock Analysts

Chimerix Tanks 81% on Failure in Phase 3 SUPPRESS Trial

Shares of biopharmaceutical firm Chimerix, Inc. CMRX plunged a massive 81.4% to touch $6.62 yesterday, following the revelation of the company’s failure to meet the primary endpoint of its Phase 3 SUPPRESS trial. The Phase 3 SUPPRESS trial aimed at evaluating the effectiveness of Chimerix’s brincidofovir (also known as CMX001) in preventing clinically significant cytomegalovirus (CMV) infection in hematopoietic cell transplant (HCT) (or stem cell transplant) patients […]